Skip to main content
. 2023 Jul 25;11:159. doi: 10.1186/s40168-023-01594-y

Table 1.

Overview of participant characteristics

Variable category Low inflammation (n=6) Medium inflammation (n=25) High Inflammation (n=12) p value
Ethnicity (Caucasian) no., % 5 (83%) 22 (88%) 9 (75%) 0.598^
Age (median ± SD; range) 25 ± 11.2 (19–46) 37 ± 12.1 (21–64) 42.5 ± 24.04 (23–88) 0.171χ
Vaginal pH (median ± SD; range) 4.25 ± 0.24 (4.0–4.7) 4.7 ± 0.44 (4.0–5.5) 4.8 ± 0.46 (4.0–5.8) 0.034χ
BV+ (Amsel criteria), no., % 0 (0%) 4 (16%) 4 (33%) 0.248^
Vaginal symptoms in the past month, any (no., %)a 4 (67%) 9 (36%) 3 (25%) 0.222^
Ectopy (no., %) 0 (0%) 7 (28%) 3 (25%) 0.473^
Any intercourse past 30 days 4 (67%) 15 (60%) 4 (42%) 0.631^
Condom use (no., %) 0 (0%) 6 (24%) 3 (25%) 0.598^
Any birth control use

1 (17%)

Oral—1

10 (40%)

Oral—2

Ring—2

IUD—6

2 (17%)

Oral—1

IUD—1

0.328^
Any STI, ever (no., %) 0 (0%) 10 (40%) 2 (17%) 0.117^
Lactobacillus dominant microbiome 6 (100%) 16 (64%) 7 (58%) 0.184^

^p value calculated using Monte Carlo to stimulate p value with Fisher’s exact test, based on 2000 iterations

χp value calculated using the Kruskal-Wallis test

aSelf-reported vaginal symptoms including pain, discomfort, itchiness, discharge, bleeding